HIV-Associated Sensory Neuropathy: Risk Factors and Genetics

Peter R Kamerman, Antonia L Wadley, Catherine Cherry

Research output: Contribution to journalArticleOther

45 Citations (Scopus)

Abstract

HIV-associated sensory neuropathy (HIV-SN) remains a common neurological complication of HIV infection despite the introduction of effective antiretroviral therapies. Exposure to neurotoxic antiretroviral drugs and increasing age have consistently been identified as risk factors for HIV-SN, while comorbid conditions with underlying predisposition to cause peripheral neuropathy (eg, diabetes mellitus, malnutrition, isoniazid exposure), ethnicity, and increasing height also have been implicated. Genetic association studies have identified genes affecting mitochondrial function and genes involved in the inflammatory response that modify the risk for HIV-SN among patients exposed to neurotoxic antiretrovirals. However, there is a lack of data on clinical, demographic, and genetic risk factors for HIV-SN in the modern era, with the rate of HIV-SN remaining unacceptably high despite the introduction of safer medications. Thus, more work is required to identify the principal factors that increase an individual?s risk for HIV-SN so that effective preventative or therapeutic strategies can be implemented
Original languageEnglish
Pages (from-to)226 - 236
Number of pages11
JournalCurrent Pain and Headache Reports
Volume16
Issue number3
DOIs
Publication statusPublished - 2012

Cite this

Kamerman, Peter R ; Wadley, Antonia L ; Cherry, Catherine. / HIV-Associated Sensory Neuropathy: Risk Factors and Genetics. In: Current Pain and Headache Reports. 2012 ; Vol. 16, No. 3. pp. 226 - 236.
@article{6c329b816b234a618c771ef506a5168a,
title = "HIV-Associated Sensory Neuropathy: Risk Factors and Genetics",
abstract = "HIV-associated sensory neuropathy (HIV-SN) remains a common neurological complication of HIV infection despite the introduction of effective antiretroviral therapies. Exposure to neurotoxic antiretroviral drugs and increasing age have consistently been identified as risk factors for HIV-SN, while comorbid conditions with underlying predisposition to cause peripheral neuropathy (eg, diabetes mellitus, malnutrition, isoniazid exposure), ethnicity, and increasing height also have been implicated. Genetic association studies have identified genes affecting mitochondrial function and genes involved in the inflammatory response that modify the risk for HIV-SN among patients exposed to neurotoxic antiretrovirals. However, there is a lack of data on clinical, demographic, and genetic risk factors for HIV-SN in the modern era, with the rate of HIV-SN remaining unacceptably high despite the introduction of safer medications. Thus, more work is required to identify the principal factors that increase an individual?s risk for HIV-SN so that effective preventative or therapeutic strategies can be implemented",
author = "Kamerman, {Peter R} and Wadley, {Antonia L} and Catherine Cherry",
year = "2012",
doi = "10.1007/s11916-012-0257-z",
language = "English",
volume = "16",
pages = "226 -- 236",
journal = "Current Pain and Headache Reports",
issn = "1531-3433",
publisher = "Springer-Verlag London Ltd.",
number = "3",

}

HIV-Associated Sensory Neuropathy: Risk Factors and Genetics. / Kamerman, Peter R; Wadley, Antonia L; Cherry, Catherine.

In: Current Pain and Headache Reports, Vol. 16, No. 3, 2012, p. 226 - 236.

Research output: Contribution to journalArticleOther

TY - JOUR

T1 - HIV-Associated Sensory Neuropathy: Risk Factors and Genetics

AU - Kamerman, Peter R

AU - Wadley, Antonia L

AU - Cherry, Catherine

PY - 2012

Y1 - 2012

N2 - HIV-associated sensory neuropathy (HIV-SN) remains a common neurological complication of HIV infection despite the introduction of effective antiretroviral therapies. Exposure to neurotoxic antiretroviral drugs and increasing age have consistently been identified as risk factors for HIV-SN, while comorbid conditions with underlying predisposition to cause peripheral neuropathy (eg, diabetes mellitus, malnutrition, isoniazid exposure), ethnicity, and increasing height also have been implicated. Genetic association studies have identified genes affecting mitochondrial function and genes involved in the inflammatory response that modify the risk for HIV-SN among patients exposed to neurotoxic antiretrovirals. However, there is a lack of data on clinical, demographic, and genetic risk factors for HIV-SN in the modern era, with the rate of HIV-SN remaining unacceptably high despite the introduction of safer medications. Thus, more work is required to identify the principal factors that increase an individual?s risk for HIV-SN so that effective preventative or therapeutic strategies can be implemented

AB - HIV-associated sensory neuropathy (HIV-SN) remains a common neurological complication of HIV infection despite the introduction of effective antiretroviral therapies. Exposure to neurotoxic antiretroviral drugs and increasing age have consistently been identified as risk factors for HIV-SN, while comorbid conditions with underlying predisposition to cause peripheral neuropathy (eg, diabetes mellitus, malnutrition, isoniazid exposure), ethnicity, and increasing height also have been implicated. Genetic association studies have identified genes affecting mitochondrial function and genes involved in the inflammatory response that modify the risk for HIV-SN among patients exposed to neurotoxic antiretrovirals. However, there is a lack of data on clinical, demographic, and genetic risk factors for HIV-SN in the modern era, with the rate of HIV-SN remaining unacceptably high despite the introduction of safer medications. Thus, more work is required to identify the principal factors that increase an individual?s risk for HIV-SN so that effective preventative or therapeutic strategies can be implemented

UR - http://link.springer.com/article/10.1007%2Fs11916-012-0257-z

U2 - 10.1007/s11916-012-0257-z

DO - 10.1007/s11916-012-0257-z

M3 - Article

VL - 16

SP - 226

EP - 236

JO - Current Pain and Headache Reports

JF - Current Pain and Headache Reports

SN - 1531-3433

IS - 3

ER -